信立泰股价跌5.07%，诺德基金旗下1只基金重仓，持有3万股浮亏损失8.07万元

Group 1 - The core point of the news is that Shenzhen Xinlitai Pharmaceutical Co., Ltd. experienced a stock decline of 5.07%, with a current share price of 50.40 yuan and a total market capitalization of 561.87 billion yuan [1] - The company was established on November 3, 1998, and went public on September 10, 2009. Its main business involves the research, production, and sales of pharmaceuticals and medical devices [1] - The revenue composition of the company is as follows: formulations account for 81.69%, medical devices 8.54%, raw materials 7.17%, and others 2.59% [1] Group 2 - From the perspective of fund holdings, Nord Fund has a significant position in Xinlitai, with the Nord Small and Medium Mixed Fund (570006) holding 30,000 shares, representing 4.71% of the fund's net value [2] - The Nord Small and Medium Mixed Fund was established on June 28, 2010, and has a current scale of 30.16 million. It has achieved a year-to-date return of 50.57% and a one-year return of 55.46% [2] - The fund manager, Zhu Mingrui, has been in position for 3 years and 56 days, with the best fund return during his tenure being 37.39% and the worst being -5.71% [3]